Cite

HARVARD Citation

    Lacroix, A. et al. (2018). Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. Lancet. 6 (1), pp. 17-26. [Online]. 
  
Back to record